Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank reported for 2023 by RA

4/1/24 SVCB

Rosneft resumes buyback

4/1/24 ROSN

Uralsib reported for 2023 by RAS

4/1/24 USBN

Yandex was listed on Moscow Exchange

4/1/24 YNDX

TGC-2 reported for 2023 by RAS

4/1/24 TGKB

Rostelecom and partners will develop import-independent PACs for fuel and energy sector

4/1/24 RTKM

Severstal shuts down blast furnace at CherMK

4/1/24 CHMF

Moscow Exchange suspends trading in X5 Retail Group receipts

4/1/24 X5

Magnit.Market opened the first points of delivery of orders

4/1/24 MGNT

Tele2 will rebrand

4/1/24 RTKM